Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote

Core Viewpoint - The Samsung Biologics Labor Union has secured a legal mandate to strike, with 95.52% of members voting in favor, highlighting significant governance and labor relations issues that pose risks to the global CDMO supply chain [1][7]. Group 1: Strike Vote and Labor Relations - Approximately 75% of Samsung Biologics' total employees are represented by the labor union, which announced an overwhelming strike vote with a turnout of 95.38% [1][7]. - The union emphasizes that the strike is not solely about wages but is rooted in deeper structural concerns regarding the company's ESG management and labor relations [3][6]. Group 2: Governance Issues - The union has raised concerns about unresolved corporate governance failures, including allegations of unfair labor practices and unauthorized use of employee personal data, which have been reported by major media [4][6]. - Management's failure to address these risks is viewed as a critical compliance risk, exacerbating the situation [4]. Group 3: Financial Performance and Wage Dispute - Despite Samsung Biologics reporting a 56.6% year-over-year increase in operating profit, management's wage offer was below the previous year's levels, indicating a lack of independent bargaining authority [5][7]. - The union argues that management's adherence to a 4.1% wage guideline set by Samsung Electronics undermines the company's own financial performance [5][7]. Group 4: Future Actions and Implications - The union plans to initiate phased strike actions, starting with an offline rally on April 22, leading to a potential general strike on May 1, unless management presents a credible proposal [6][7]. - The union warns that unresolved labor disputes and governance issues could directly threaten the supply chain of international clients in the CDMO industry [6][9].